PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

98 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
▮◀ ◀◀ 1 ... 2 ... 3 ... 4 ... 5 ... ▶▶ ▶▮
Alle Publikationen dieser Seite in den Korb legen
41.
Sailer, N.* et al.: T-cells expressing a highly potent PRAME-specific T-cell receptor in combination with a chimeric PD1-41BB co-stimulatory receptor show a favorable preclinical safety profile and strong anti-tumor reactivity. Cancers 14:1998 (2022)
42.
Schültke, E.* et al.: Good Timing Matters: The spatially fractionated high dose rate boost should come first. Cancers 14:5964 (2022)
43.
Tanno, B.* et al.: MiRNA-mediated fibrosis in the out-of-target heart following partial-body irradiation. Cancers 14:3463 (2022)
44.
Trassl, L. & Stathopoulos, G.T.: KRAS pathway alterations in malignant pleural mesothelioma: An underestimated player. Cancers 14:4303 (2022)
45.
Wagner, A.* et al.: Surgical and functional outcome after resection of 64 petroclival meningiomas. Cancers 14:4517 (2022)
46.
Xue, B.* et al.: T cells directed against the metastatic driver chondromodulin-1 in ewing sarcoma: Comparative engineering with CRISPR/Cas9 vs. retroviral gene transfer for adoptive transfer. Cancers 14:5485 (2022)
47.
Zhao, X.* et al.: Validation of novel molecular imaging targets identified by functional genomic mRNA profiling to detect dysplasia in Barrett's Esophagus. Cancers 14:2462 (2022)
48.
Aftahy, A.K.* et al.: Surgical management of jugular foramen schwannomas. Cancers 13:4218 (2021)
49.
Baumeister, P. ; Zhou, J.* ; Canis, M.* & Gires, O.: Epithelial-to-mesenchymal transition-derived heterogeneity in head and neck squamous cell carcinomas. Cancers 13:5355 (2021)
50.
Borm, K.J.* et al.: Excluding lung tissue from the ptv during internal mammary irradiation. A safe technique for oar-sparing? Cancers 13:1951 (2021)
51.
Borm, K.J.* et al.: A comprehensive prospective comparison of acute skin toxicity after hypofractionated and normofractionated radiation therapy in breast cancer. Cancers 13:5826 (2021)
52.
Brunn, D.* et al.: Interferon regulatory factor 9 promotes lung cancer progression via regulation of versican. Cancers 13:208 (2021)
53.
Dobiasch, S. et al.: Histopathological tumor and normal tissue responses after 3d-planned arc radiotherapy in an orthotopic xenograft mouse model of human pancreatic cancer. Cancers 13:5656 (2021)
54.
Freuer, D.* et al.: Body fat distribution and risk of breast, endometrial, and ovarian cancer: A two-sample mendelian randomization study. Cancers 13:5053 (2021)
55.
Gottschlich, A.* ; Endres, S. & Kobold, S.: Therapeutic strategies for targeting IL-1 in cancer. Cancers 13:477 (2021)
56.
Gulde, S. et al.: Gender-specific efficacy revealed by head-to-head comparison of pasireotide and octreotide in a representative in vivo model of nonfunctioning pituitary tumors. Cancers 13:3097 (2021)
57.
Gutschenritter, T.* et al.: The judicious use of stereotactic radiosurgery and hypofractionated stereotactic radiotherapy in the management of large brain metastases. Cancers 13:70 (2021)
58.
Jansen, L.* et al.: Estimation of the potentially avoidable excess deaths associated with socioeconomic inequalities in cancer survival in Germany. Cancers 13:357 (2021)
59.
Klymenko, O.* et al.: Radiooncological view on therapy outcome after multidisciplinary treatment of sinonasal tumors. Cancers 13:2364 (2021)
60.
Kraus, K.M. et al.: Potential morbidity reduction for lung stereotactic body radiation therapy using respiratory gating. Cancers 13:5092 (2021)
▮◀ ◀◀ 1 ... 2 ... 3 ... 4 ... 5 ... ▶▶ ▶▮